Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

550 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.
Lee PP, Yee C, Savage PA, Fong L, Brockstedt D, Weber JS, Johnson D, Swetter S, Thompson J, Greenberg PD, Roederer M, Davis MM. Lee PP, et al. Among authors: fong l. Nat Med. 1999 Jun;5(6):677-85. doi: 10.1038/9525. Nat Med. 1999. PMID: 10371507
Donor blood monocytes but not T or B cells facilitate long-term allograft survival after total lymphoid irradiation.
Hayamizu K, Zeng D, Huie P, Garcia-Ojeda ME, Bloch DA, Fong L, Engleman EG, Sibley RK, Strober S. Hayamizu K, et al. Among authors: fong l. Transplantation. 1998 Sep 15;66(5):585-93. doi: 10.1097/00007890-199809150-00006. Transplantation. 1998. PMID: 9753336
Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration.
Brockstedt DG, Podsakoff GM, Fong L, Kurtzman G, Mueller-Ruchholtz W, Engleman EG. Brockstedt DG, et al. Among authors: fong l. Clin Immunol. 1999 Jul;92(1):67-75. doi: 10.1006/clim.1999.4724. Clin Immunol. 1999. PMID: 10413654
Dendritic cells in cancer immunotherapy.
Fong L, Engleman EG. Fong L, et al. Annu Rev Immunol. 2000;18:245-73. doi: 10.1146/annurev.immunol.18.1.245. Annu Rev Immunol. 2000. PMID: 10837059 Review.
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy.
Fong L, Hou Y, Rivas A, Benike C, Yuen A, Fisher GA, Davis MM, Engleman EG. Fong L, et al. Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8809-14. doi: 10.1073/pnas.141226398. Epub 2001 Jun 26. Proc Natl Acad Sci U S A. 2001. PMID: 11427731 Free PMC article. Clinical Trial.
In vivo manipulation of dendritic cells to induce therapeutic immunity.
Merad M, Sugie T, Engleman EG, Fong L. Merad M, et al. Among authors: fong l. Blood. 2002 Mar 1;99(5):1676-82. doi: 10.1182/blood.v99.5.1676. Blood. 2002. PMID: 11861283
Induction of immunity to tumor-associated antigens following dendritic cell vaccination of cancer patients.
Engleman EG, Fong L. Engleman EG, et al. Among authors: fong l. Clin Immunol. 2003 Jan;106(1):10-5. doi: 10.1016/s1521-6616(02)00016-5. Clin Immunol. 2003. PMID: 12584045 No abstract available.
Distinct CD8+ T cell repertoires primed with agonist and native peptides derived from a tumor-associated antigen.
Hou Y, Kavanagh B, Fong L. Hou Y, et al. Among authors: fong l. J Immunol. 2008 Feb 1;180(3):1526-34. doi: 10.4049/jimmunol.180.3.1526. J Immunol. 2008. PMID: 18209048
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade.
Fassò M, Waitz R, Hou Y, Rim T, Greenberg NM, Shastri N, Fong L, Allison JP. Fassò M, et al. Among authors: fong l. Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3509-14. doi: 10.1073/pnas.0712269105. Epub 2008 Feb 26. Proc Natl Acad Sci U S A. 2008. PMID: 18303116 Free PMC article.
CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion.
Kavanagh B, O'Brien S, Lee D, Hou Y, Weinberg V, Rini B, Allison JP, Small EJ, Fong L. Kavanagh B, et al. Among authors: fong l. Blood. 2008 Aug 15;112(4):1175-83. doi: 10.1182/blood-2007-11-125435. Epub 2008 Jun 3. Blood. 2008. PMID: 18523152 Free PMC article. Clinical Trial.
550 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page